2020 Q3 Form 10-Q Financial Statement
#000156459020053534 Filed on November 12, 2020
Income Statement
| Concept | 2020 Q3 | 2019 Q3 | 2019 Q2 |
|---|---|---|---|
| Revenue | $1.481M | $2.096M | $2.321M |
| YoY Change | -29.34% | -34.4% | -23.6% |
| Cost Of Revenue | $563.0K | $799.0K | $857.0K |
| YoY Change | -29.54% | -39.24% | -21.74% |
| Gross Profit | $918.0K | $1.297M | $1.464M |
| YoY Change | -29.22% | -31.01% | -24.65% |
| Gross Profit Margin | 61.99% | 61.88% | 63.08% |
| Selling, General & Admin | $1.461M | $2.005M | $2.137M |
| YoY Change | -27.13% | 4.05% | 15.02% |
| % of Gross Profit | 159.15% | 154.59% | 145.97% |
| Research & Development | $255.0K | $115.0K | $268.0K |
| YoY Change | 121.74% | -81.33% | -40.71% |
| % of Gross Profit | 27.78% | 8.87% | 18.31% |
| Depreciation & Amortization | $64.00K | $40.00K | $66.00K |
| YoY Change | 60.0% | -11.11% | 50.0% |
| % of Gross Profit | 6.97% | 3.08% | 4.51% |
| Operating Expenses | $1.716M | $2.110M | $2.405M |
| YoY Change | -18.67% | -17.03% | 4.11% |
| Operating Profit | -$798.0K | -$813.0K | -$941.0K |
| YoY Change | -1.85% | 22.62% | 156.4% |
| Interest Expense | $28.00K | $816.0K | $20.00K |
| YoY Change | -96.57% | 4700.0% | 185.71% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $816.0K | $293.0K | |
| YoY Change | 1797.67% | -1185.19% | |
| Pretax Income | -$544.0K | $3.000K | -$648.0K |
| YoY Change | -18233.33% | -97.52% | 66.15% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$544.0K | $3.000K | -$648.0K |
| YoY Change | -18233.33% | -97.52% | 64.47% |
| Net Earnings / Revenue | -36.73% | 0.14% | -27.92% |
| Basic Earnings Per Share | -$0.09 | ||
| Diluted Earnings Per Share | -$72.16K | $397.60 | -$0.09 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 7.533M | 7.533M | |
| Diluted Shares Outstanding | 7.533M |
Balance Sheet
| Concept | 2020 Q3 | 2019 Q3 | 2019 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $1.026M | $463.0K | $600.0K |
| YoY Change | 121.6% | -22.18% | 25.0% |
| Cash & Equivalents | $1.026M | $463.0K | $600.0K |
| Short-Term Investments | |||
| Other Short-Term Assets | $159.0K | $307.0K | $440.0K |
| YoY Change | -48.21% | -30.23% | -22.81% |
| Inventory | $937.0K | $1.409M | $1.317M |
| Prepaid Expenses | |||
| Receivables | $509.0K | $1.080M | $976.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $2.631M | $3.259M | $3.328M |
| YoY Change | -19.27% | -2.07% | -23.32% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $1.507M | $1.475M | $697.0K |
| YoY Change | 2.17% | 325.07% | 83.42% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | $2.790M | ||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $447.0K | $835.0K | $880.0K |
| YoY Change | -46.47% | -4.79% | 12.82% |
| Total Long-Term Assets | $3.220M | $5.001M | $5.213M |
| YoY Change | -35.61% | -4.07% | 27.77% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $2.631M | $3.259M | $3.328M |
| Total Long-Term Assets | $3.220M | $5.001M | $5.213M |
| Total Assets | $5.851M | $8.260M | $8.541M |
| YoY Change | -29.16% | -3.29% | 1.44% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $391.0K | $722.0K | $731.0K |
| YoY Change | -45.84% | -1.23% | -59.84% |
| Accrued Expenses | $706.0K | $887.0K | $548.0K |
| YoY Change | -20.41% | 9.1% | -33.17% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $2.448M | $1.848M | $0.00 |
| YoY Change | 32.47% | ||
| Long-Term Debt Due | $57.00K | ||
| YoY Change | |||
| Total Short-Term Liabilities | $3.852M | $3.707M | $4.458M |
| YoY Change | 3.91% | -16.85% | -34.15% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $599.0K | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $976.0K | $929.0K | $970.0K |
| YoY Change | 5.06% | -4.62% | |
| Total Long-Term Liabilities | $1.575M | $929.0K | $970.0K |
| YoY Change | 69.54% | -4.62% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.852M | $3.707M | $4.458M |
| Total Long-Term Liabilities | $1.575M | $929.0K | $970.0K |
| Total Liabilities | $5.427M | $4.636M | $5.432M |
| YoY Change | 17.06% | -14.65% | -19.76% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$108.4M | -$103.7M | |
| YoY Change | 4.55% | ||
| Common Stock | $8.000K | $8.000K | |
| YoY Change | 0.0% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$3.876M | -$676.0K | -$1.191M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $5.851M | $8.260M | $8.540M |
| YoY Change | -29.16% | -3.29% | 1.43% |
Cashflow Statement
| Concept | 2020 Q3 | 2019 Q3 | 2019 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$544.0K | $3.000K | -$648.0K |
| YoY Change | -18233.33% | -97.52% | 64.47% |
| Depreciation, Depletion And Amortization | $64.00K | $40.00K | $66.00K |
| YoY Change | 60.0% | -11.11% | 50.0% |
| Cash From Operating Activities | -$277.0K | -$27.00K | -$648.0K |
| YoY Change | 925.93% | -95.14% | 27.06% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$12.00K | -$105.0K | -$172.0K |
| YoY Change | -88.57% | -18.6% | -14.0% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$12.00K | -$105.0K | -$172.0K |
| YoY Change | -88.57% | -18.6% | -14.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | 0.000 | 800.0K |
| YoY Change | -100.0% | 8.11% | |
| NET CHANGE | |||
| Cash From Operating Activities | -277.0K | -27.00K | -648.0K |
| Cash From Investing Activities | -12.00K | -105.0K | -172.0K |
| Cash From Financing Activities | 0.000 | 0.000 | 800.0K |
| Net Change In Cash | -289.0K | -132.0K | -20.00K |
| YoY Change | 118.94% | -119.21% | -166.67% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$277.0K | -$27.00K | -$648.0K |
| Capital Expenditures | -$12.00K | -$105.0K | -$172.0K |
| Free Cash Flow | -$265.0K | $78.00K | -$476.0K |
| YoY Change | -439.74% | -118.27% | 53.55% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Interest Paid Net
InterestPaidNet
|
4000 | ||
| us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
421000 | ||
| isco |
Patent License Costs Included In Accrued Liabilities
PatentLicenseCostsIncludedInAccruedLiabilities
|
6000 | ||
| us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1049000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
6635000 | ||
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1347000 | ||
| CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1086000 | |
| CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
273000 | |
| CY2019Q1 | isco |
Adjustments Related To Error Correction In Equity
AdjustmentsRelatedToErrorCorrectionInEquity
|
-4300000 | |
| CY2019Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1049000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-906000 | |
| CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1191000 | |
| us-gaap |
Profit Loss
ProfitLoss
|
-1552000 | ||
| us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
222000 | ||
| isco |
Inventory Adjustment
InventoryAdjustment
|
36000 | ||
| isco |
Inventory Adjustment
InventoryAdjustment
|
89000 | ||
| us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
78000 | ||
| us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
51000 | ||
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
65000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1006000 | ||
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-248000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-48000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
146000 | ||
| us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
654000 | ||
| us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
800000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
654000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
542000 | ||
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
484000 | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7502000 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
5652000 | ||
| us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
2000 | ||
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
418000 | |
| CY2020Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
40000 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.27 | ||
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.21 | ||
| CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
324000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
718000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7539089 | |
| CY2020Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
8000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2888000 | |
| CY2020Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7539089 | |
| CY2019Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
103490000 | |
| CY2020Q3 | isco |
Paycheck Protection Program Loan Current
PaycheckProtectionProgramLoanCurrent
|
57000 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-106391000 | |
| CY2020Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7539089 | |
| CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
5208000 | |
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7539089 | |
| CY2020Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
936000 | |
| CY2020Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5851000 | |
| CY2020Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
104505000 | |
| CY2020Q3 | us-gaap |
Liabilities
Liabilities
|
5427000 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-108394000 | |
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3876000 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6620000 | |
| CY2020Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
8000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
120000000 | |
| CY2020Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1481000 | |
| CY2019Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2096000 | |
| us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ProductMember | ||
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
2138000 | ||
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
2497000 | ||
| CY2019Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2370000 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
758000 | ||
| CY2020Q3 | isco |
Paycheck Protection Program Loan Noncurrent
PaycheckProtectionProgramLoanNoncurrent
|
599000 | |
| us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ProductMember | ||
| CY2019Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
207000 | |
| us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7539000 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2085000 | ||
| CY2019Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.00 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7539000 | |
| CY2020Q3 | us-gaap |
Interest Expense
InterestExpense
|
28000 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4324000 | ||
| CY2019Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7546000 | |
| us-gaap |
Profit Loss
ProfitLoss
|
-2003000 | ||
| us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
199000 | ||
| CY2020Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-282000 | |
| us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-26000 | ||
| us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
12000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-263000 | ||
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
264000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-272000 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
84000 | ||
| isco |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-238000 | ||
| isco |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-224000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-30000 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1016000 | ||
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
24000 | ||
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
58000 | ||
| us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
250000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-82000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-396000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
800000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-612000 | ||
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1075000 | |
| CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1026000 | |
| CY2019Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
463000 | |
| us-gaap |
Interest Paid Net
InterestPaidNet
|
4000 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1001000 | ||
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2537000 | |
| CY2020Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
12000 | |
| CY2008Q2 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
| CY2008Q2 | isco |
Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
|
250000 | |
| us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
0 | ||
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
506000 | |
| us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three and nine months ended September 30, 2020, the Company reclassified certain prior period amounts to conform to the current period presentation, as follows:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying value and shares of the Company’s Series B, Series G, Series I-1 and Series I-2 non-redeemable convertible preferred stock were aggregated on the accompanying condensed consolidated balance sheets and statements of changes in redeemable convertible preferred stock and stockholders’ deficit. Refer to Note 6 – Convertible Preferred Stock and Stockholders’ Deficit for further discussion;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash operating lease expense was reclassified from changes in operating assets and liabilities to adjustments to reconcile net loss to net cash used in operating activities on the accompanying condensed consolidated statements of cash flows; and</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financed insurance premiums and payments on financed insurance premiums were reclassified from non-cash financing activities and cash flows from financing activities, respectively, to cash flows from operating activities on the accompanying condensed consolidated statements of cash flows.</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These reclassifications had no effect on previously reported net income (loss), stockholders’ deficit or cash flows for the prior period.</p> | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying condensed consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values, allowance for excess and obsolete inventories, allowance for sales returns and doubtful accounts, and transactions using the Black-Scholes option valuation model, for example, common stock options and common stock warrants, as well as the Monte-Carlo simulation method for certain common stock warrants. Actual results could differ from those estimates.</p> | ||
| isco |
Number Of Business Units
NumberOfBusinessUnits
|
2 | ||
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
12000 | |
| us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P15Y | ||
| us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | ||
| us-gaap |
Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
|
The Company's revenue consists primarily of sales of products from its two revenue-generating operating segments, the biomedical products market and anti-aging products market business segments. The biomedical market segment markets and sells primary human cell research products with two product categories, cells and media, which are sold both domestically within the United States and internationally. The anti-aging market segment markets and sells a line of skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers. | ||
| us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | ||
| isco |
Product Return Guarantee Period
ProductReturnGuaranteePeriod
|
P30D | ||
| isco |
Allowance For Sales Return
AllowanceForSalesReturn
|
0 | ||
| CY2019 | isco |
Allowance For Sales Return
AllowanceForSalesReturn
|
0 | |
| CY2020Q3 | isco |
Financial Assets Fair Value Disclosure
FinancialAssetsFairValueDisclosure
|
0 | |
| CY2020Q3 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
0 | |
| CY2020Q3 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
| CY2020Q3 | us-gaap |
Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
|
0 | |
| CY2020Q3 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
| CY2020Q3 | us-gaap |
Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
|
0 | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | ||
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | ||
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | ||
| CY2014Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
| CY2016Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
| CY2020Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
273000 | |
| CY2019Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
512000 | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1015000 | ||
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1589000 | ||
| CY2020Q3 | us-gaap |
Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
|
true | |
| CY2020Q3 | us-gaap |
Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
|
2020-01-01 | |
| CY2020Q2 | isco |
Paycheck Protection Program Loan Maturity Period
PaycheckProtectionProgramLoanMaturityPeriod
|
P2Y | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14811628 | ||
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15510887 | ||
| CY2020Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14791977 | |
| CY2020Q2 | isco |
Paycheck Protection Program Loan Interest Rate
PaycheckProtectionProgramLoanInterestRate
|
0.01 | |
| us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | ||
| CY2019Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
207000 | |
| CY2020Q3 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
40000 | |
| CY2020Q2 | isco |
Paycheck Protection Program Loan Deferred Payment Period
PaycheckProtectionProgramLoanDeferredPaymentPeriod
|
P10M | |
| CY2019Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15661641 | |
| CY2020Q2 | isco |
Paycheck Protection Program Loan Forgiveness Period
PaycheckProtectionProgramLoanForgivenessPeriod
|
P168D | |
| CY2020Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | |
| CY2020Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q3 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
644000 | |
| CY2019Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
795000 | |
| CY2020Q3 | isco |
Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
|
1320000 | |
| CY2019Q4 | isco |
Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
|
1604000 | |
| CY2020Q3 | isco |
Disposed Of Obsolete Inventory
DisposedOfObsoleteInventory
|
121000 | |
| CY2020Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3434000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3410000 | |
| CY2020Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2866000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2742000 | |
| CY2020Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
42000 | |
| CY2019Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
40000 | |
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
124000 | ||
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
115000 | ||
| CY2020Q3 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
2267000 | |
| CY2019Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
2268000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1076000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1008000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1191000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1260000 | |
| CY2020Q3 | isco |
Indefinite Life Logos And Trademarks
IndefiniteLifeLogosAndTrademarks
|
75000 | |
| CY2019Q4 | isco |
Indefinite Life Logos And Trademarks
IndefiniteLifeLogosAndTrademarks
|
75000 | |
| CY2020Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1266000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1335000 | |
| CY2020Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
23000 | |
| CY2019Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
26000 | |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
68000 | ||
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
88000 | ||
| CY2020Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
65000 | |
| CY2019Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
145000 | |
| us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
65000 | ||
| us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
145000 | ||
| CY2020Q2 | isco |
Cares Act Of2020 Aid Amount
CARESActOf2020AidAmount
|
654000 | |
| CY2020Q3 | us-gaap |
Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
|
true | |
| us-gaap |
Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
|
us-gaap:AccountingStandardsUpdate201813Member | ||
| CY2020Q3 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
484000 | |
| CY2019Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
688000 | |
| CY2020Q3 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
430000 | |
| CY2019Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
492000 | |
| CY2020Q3 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1050000 | |
| CY2019Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1219000 | |
| CY2020Q3 | us-gaap |
Inventory Gross
InventoryGross
|
1964000 | |
| CY2019Q4 | us-gaap |
Inventory Gross
InventoryGross
|
2399000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1000000 | |
| CY2019Q1 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
49000 | |
| isco |
Convertible Common Stock Conversion Price
ConvertibleCommonStockConversionPrice
|
1.75 | ||
| CY2014Q4 | isco |
Class Of Warrant Or Right Issued Exercisable For Shares Of Common Stock
ClassOfWarrantOrRightIssuedExercisableForSharesOfCommonStock
|
62047 | |
| CY2016Q1 | isco |
Class Of Warrant Or Right Issued Exercisable For Shares Of Common Stock
ClassOfWarrantOrRightIssuedExercisableForSharesOfCommonStock
|
11159995 | |
| CY2020Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
845000 | |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y | ||
| CY2020Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
19618122 | |
| isco |
Related Party Rent Expense
RelatedPartyRentExpense
|
127000 | ||
| isco |
Related Party Rent Expense
RelatedPartyRentExpense
|
120000 | ||
| CY2019Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
800000 | |
| CY2019Q4 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
500000 | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
354000 | ||
| CY2019Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
500000 | |
| isco |
Number Of Operating Leases
NumberOfOperatingLeases
|
3 | ||
| CY2020Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1268000 | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
370000 | ||
| us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
6000 | ||
| us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
9000 | ||
| CY2020Q3 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
0 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
128000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
517000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
394000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
255000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
233000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
240000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1767000 | |
| CY2020Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
499000 |
